Sanford Markowitz, M.D., Ph.D.
Sanford Markowitz, M.D., Ph.D., is Markowitz-Ingalls Professor of Cancer Genetics at the Case Western Reserve University School of Medicine. He is also Principal Investigator of the Case Gastrointestinal SPORE, an NCI-Designated Specialized Program of Research Excellence in Gastrointestinal Cancers. After studying at Yale and completing his medical residency at the University of Chicago, Dr. Markowitz became a Fellow at the NCI-Navy Medical Oncology Branch, headed by John Minna, M.D. From there, he accepted a position at Case Western, where he built the foundations of a colon cancer clinical research program with his colleague and fellow NCI alum, James Willson, M.D.
To learn more about Dr. Markowitz’s career and research, read Gut Check: A Career in Colon Cancer Research (CCR connections, Vol. 8, No. 1, 2014).
Anne Hosmalin, M.D., Ph.D.
Anne Hosmalin, M.D., Ph.D., is a Research Director and Professor at the Cochin Institute in Paris, France. She obtained her M.D. from Descartes University in 1986 and her Ph.D. in Immunology from Pierre & Marie Curie University. Her three-year postdoctoral Fogarty fellowship with Jay Berzofsky, M.D., Ph.D., now Chief of CCR’s Vaccine Branch, in the early days of HIV vaccine research, kindled interests that still form the basis of her current research agenda. Her work spans basic investigations into the roles of antigen-presenting cells in orchestrating immune responses to the quest for more effective vaccines. She also serves as President of the French Society of Immunology.
To learn more about Dr. Hosmalin’s research career, read Cross-Presentation: For Better or Worse (CCR connections, Vol. 7, No. 2, 2013).
Peter C. Adamson, M.D.
Peter C. Adamson, M.D., is Chair of the Children’s Oncology Group—an NCI-supported consortium of more than 200 centers across North America, Australia, New Zealand, and parts of Europe. Dr. Adamson completed 12 years of subspecialty training in NCI’s Pediatric Oncology Branch under the leadership and guidance of its Chief at that time, Philip Pizzo, M.D. “I had the distinct privilege of having two of our fields’ most outstanding mentors, David Poplack, M.D., and Frank Balis, M.D.”, Dr. Adamson recalls.
To learn more about Dr. Adamson’s career, read A Forceful Advocate for Young Cancer Patients (CCR connections, Vol. 6, No. 1, 2012).
Joyce O’Shaughnessy, M.D.
Joyce O’Shaughnessy, M.D., spent 10 years at NCI, initially as a Clinical Associate, then as a Senior Investigator and Special Assistant to NCI Director, Samuel Broder, M.D., and finally as a Senior Investigator in NCI’s Intramural Breast Cancer Research Program. O’Shaughnessy is now a Medical Oncologist with Texas Oncology and the Baylor-Sammons Cancer Center in Dallas, Texas. She is also Co-Chair of the Breast Cancer Research Program at U.S. Oncology, a practice management company that operates clinical trials across its national network through a structure that resembles NCI Clinical Trials Cooperative Groups. A major focus of her clinical research is on triple-negative breast cancers.
To learn more about Dr. O’Shaughnessy’s career, read Breast Cancer: The Triple-Negative Problem (CCR connections, Vol. 5, No. 1, 2011).